1. Home
  2. MCBS vs NAGE Comparison

MCBS vs NAGE Comparison

Compare MCBS & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

HOLD

Current Price

$26.65

Market Cap

669.6M

Sector

Finance

ML Signal

HOLD

Logo Niagen Bioscience Inc. Common Stock

NAGE

Niagen Bioscience Inc. Common Stock

HOLD

Current Price

$6.73

Market Cap

766.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCBS
NAGE
Founded
2006
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
669.6M
766.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MCBS
NAGE
Price
$26.65
$6.73
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$31.00
$16.33
AVG Volume (30 Days)
51.6K
1.0M
Earning Date
10-17-2025
11-04-2025
Dividend Yield
3.75%
N/A
EPS Growth
11.15
1093.81
EPS
2.59
0.23
Revenue
$147,349,000.00
$124,709,000.00
Revenue This Year
$18.90
$29.51
Revenue Next Year
$27.50
$20.55
P/E Ratio
$10.29
$28.82
Revenue Growth
8.69
36.04
52 Week Low
$24.24
$5.16
52 Week High
$35.45
$14.69

Technical Indicators

Market Signals
Indicator
MCBS
NAGE
Relative Strength Index (RSI) 56.79 40.05
Support Level $25.84 $6.79
Resistance Level $27.10 $7.11
Average True Range (ATR) 0.65 0.28
MACD 0.20 0.04
Stochastic Oscillator 85.42 12.30

Price Performance

Historical Comparison
MCBS
NAGE

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: